GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rreb1
|
ENSRNOG00000015701 | ras responsive element binding protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Rreb1 | rn6_v1_chr17_-_27665266_27665266 | 0.46 | 2.8e-18 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_100577056 | 62.20 |
ENSRNOT00000026992
|
Napsa
|
napsin A aspartic peptidase |
chr9_-_80167033 | 30.63 |
ENSRNOT00000023530
|
Igfbp5
|
insulin-like growth factor binding protein 5 |
chr8_-_7426611 | 27.91 |
ENSRNOT00000031492
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr1_+_40086470 | 21.05 |
ENSRNOT00000021895
|
Iyd
|
iodotyrosine deiodinase |
chr18_-_64177729 | 20.91 |
ENSRNOT00000022347
|
Mc2r
|
melanocortin 2 receptor |
chr6_+_3657325 | 20.08 |
ENSRNOT00000010927
|
Tmem178a
|
transmembrane protein 178A |
chr3_-_9326993 | 19.27 |
ENSRNOT00000090137
|
Lamc3
|
laminin subunit gamma 3 |
chr5_-_100647727 | 18.63 |
ENSRNOT00000067435
|
Nfib
|
nuclear factor I/B |
chr2_-_23289266 | 18.17 |
ENSRNOT00000061708
|
Bhmt2
|
betaine-homocysteine S-methyltransferase 2 |
chr5_-_7874909 | 18.03 |
ENSRNOT00000064774
|
Prex2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
chr1_+_215609645 | 17.78 |
ENSRNOT00000076140
ENSRNOT00000027487 |
Tnni2
|
troponin I2, fast skeletal type |
chr7_-_120077612 | 17.58 |
ENSRNOT00000011750
|
Lgals2
|
galectin 2 |
chr20_+_4363508 | 17.53 |
ENSRNOT00000077205
|
Ager
|
advanced glycosylation end product-specific receptor |
chr7_+_38742051 | 17.49 |
ENSRNOT00000006070
|
Dcn
|
decorin |
chr10_-_10767389 | 17.20 |
ENSRNOT00000066754
|
Smim22
|
small integral membrane protein 22 |
chr12_+_41543696 | 16.10 |
ENSRNOT00000079639
|
Tpcn1
|
two pore segment channel 1 |
chr6_+_111180108 | 15.93 |
ENSRNOT00000082027
|
Gstz1
|
glutathione S-transferase zeta 1 |
chr1_-_131460473 | 15.58 |
ENSRNOT00000084336
|
Nr2f2
|
nuclear receptor subfamily 2, group F, member 2 |
chr12_+_17734133 | 15.42 |
ENSRNOT00000042117
|
Pdgfa
|
platelet derived growth factor subunit A |
chr10_+_86950557 | 15.37 |
ENSRNOT00000014153
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr1_-_256813711 | 15.30 |
ENSRNOT00000021055
|
Rbp4
|
retinol binding protein 4 |
chr2_+_236625357 | 15.19 |
ENSRNOT00000081248
|
Papss1
|
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
chr19_-_40925660 | 14.88 |
ENSRNOT00000023645
|
Mtss1l
|
MTSS1L, I-BAR domain containing |
chr3_+_8832740 | 14.63 |
ENSRNOT00000022552
|
Phyhd1
|
phytanoyl-CoA dioxygenase domain containing 1 |
chr1_+_191829555 | 14.09 |
ENSRNOT00000067138
|
Scnn1b
|
sodium channel epithelial 1 beta subunit |
chr12_+_38144855 | 13.81 |
ENSRNOT00000032274
|
Hcar1
|
hydroxycarboxylic acid receptor 1 |
chr2_+_23289374 | 13.59 |
ENSRNOT00000090666
ENSRNOT00000032783 |
Dmgdh
|
dimethylglycine dehydrogenase |
chr2_+_60949256 | 13.51 |
ENSRNOT00000025323
ENSRNOT00000040701 |
Amacr
|
alpha-methylacyl-CoA racemase |
chr14_-_92577936 | 13.22 |
ENSRNOT00000086154
|
Cobl
|
cordon-bleu WH2 repeat protein |
chr10_+_56710464 | 13.10 |
ENSRNOT00000065370
ENSRNOT00000064064 |
Asgr2
|
asialoglycoprotein receptor 2 |
chr5_-_100647298 | 12.51 |
ENSRNOT00000067538
ENSRNOT00000013092 |
Nfib
|
nuclear factor I/B |
chr8_+_62472095 | 12.50 |
ENSRNOT00000026473
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1 |
chr20_+_4363152 | 12.36 |
ENSRNOT00000000508
ENSRNOT00000084841 ENSRNOT00000072848 ENSRNOT00000077561 |
Ager
|
advanced glycosylation end product-specific receptor |
chr10_-_58973020 | 12.32 |
ENSRNOT00000020379
|
Smtnl2
|
smoothelin-like 2 |
chr2_+_198303168 | 12.28 |
ENSRNOT00000056262
|
Mtmr11
|
myotubularin related protein 11 |
chr2_-_195423787 | 12.05 |
ENSRNOT00000071603
|
LOC103689947
|
selenium-binding protein 1 |
chr16_+_31734944 | 11.75 |
ENSRNOT00000059673
|
Palld
|
palladin, cytoskeletal associated protein |
chr18_+_15467870 | 11.65 |
ENSRNOT00000091696
|
B4galt6
|
beta-1,4-galactosyltransferase 6 |
chr2_+_210045161 | 11.28 |
ENSRNOT00000024455
|
Slc16a4
|
solute carrier family 16, member 4 |
chr16_+_4469468 | 11.04 |
ENSRNOT00000021164
|
Wnt5a
|
wingless-type MMTV integration site family, member 5A |
chr20_-_4542073 | 10.94 |
ENSRNOT00000000477
|
Cfb
|
complement factor B |
chr2_-_196113149 | 10.89 |
ENSRNOT00000088465
|
Selenbp1
|
selenium binding protein 1 |
chr1_+_215609036 | 10.74 |
ENSRNOT00000076187
|
Tnni2
|
troponin I2, fast skeletal type |
chr20_-_14025067 | 10.65 |
ENSRNOT00000093430
ENSRNOT00000074533 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr16_+_20521956 | 10.64 |
ENSRNOT00000026597
|
Pgpep1
|
pyroglutamyl-peptidase I |
chr4_-_157372861 | 10.58 |
ENSRNOT00000021578
|
P3h3
|
prolyl 3-hydroxylase 3 |
chr5_-_135001720 | 10.31 |
ENSRNOT00000035348
|
Lurap1
|
leucine rich adaptor protein 1 |
chr3_-_117766120 | 10.04 |
ENSRNOT00000056022
|
Fbn1
|
fibrillin 1 |
chr4_+_114835064 | 9.96 |
ENSRNOT00000031964
|
LOC103692165
|
rhotekin |
chr7_+_144647587 | 9.92 |
ENSRNOT00000022398
|
Hoxc4
|
homeo box C4 |
chr1_-_22748422 | 9.81 |
ENSRNOT00000021944
|
Slc18b1
|
solute carrier family 18 member B1 |
chr5_+_80920568 | 9.68 |
ENSRNOT00000076467
ENSRNOT00000076111 ENSRNOT00000040898 |
Pappa
|
pregnancy-associated plasma protein A |
chr11_-_37993204 | 9.60 |
ENSRNOT00000077050
ENSRNOT00000091614 ENSRNOT00000002683 |
Fam3b
|
family with sequence similarity 3, member B |
chrX_-_75566481 | 9.59 |
ENSRNOT00000003714
|
Zdhhc15
|
zinc finger, DHHC-type containing 15 |
chr16_-_48981980 | 9.28 |
ENSRNOT00000014235
|
Acsl1
|
acyl-CoA synthetase long-chain family member 1 |
chr3_+_3310954 | 9.18 |
ENSRNOT00000061773
|
Kcnt1
|
potassium sodium-activated channel subfamily T member 1 |
chr1_+_163445527 | 9.16 |
ENSRNOT00000020520
|
Lrrc32
|
leucine rich repeat containing 32 |
chr3_-_29996865 | 9.15 |
ENSRNOT00000080382
|
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr16_-_81912738 | 9.14 |
ENSRNOT00000087095
|
Mcf2l
|
MCF.2 cell line derived transforming sequence-like |
chr4_-_168297373 | 9.10 |
ENSRNOT00000066575
|
Lrp6
|
LDL receptor related protein 6 |
chr10_+_13797562 | 9.09 |
ENSRNOT00000011784
ENSRNOT00000083312 |
Eci1
|
enoyl-CoA delta isomerase 1 |
chr6_+_107531528 | 9.07 |
ENSRNOT00000077555
|
Acot3
|
acyl-CoA thioesterase 3 |
chr8_+_130401470 | 9.01 |
ENSRNOT00000043346
|
Zbtb47
|
zinc finger and BTB domain containing 47 |
chr1_-_140262452 | 8.98 |
ENSRNOT00000046849
ENSRNOT00000045165 ENSRNOT00000025536 ENSRNOT00000041839 |
Ntrk3
|
neurotrophic receptor tyrosine kinase 3 |
chr10_+_20320878 | 8.90 |
ENSRNOT00000009714
|
Slit3
|
slit guidance ligand 3 |
chr1_+_107344904 | 8.80 |
ENSRNOT00000082582
|
Gas2
|
growth arrest-specific 2 |
chr19_-_37916813 | 8.72 |
ENSRNOT00000026585
|
Lcat
|
lecithin cholesterol acyltransferase |
chr17_-_22143324 | 8.72 |
ENSRNOT00000019361
|
Edn1
|
endothelin 1 |
chr10_+_86657285 | 8.57 |
ENSRNOT00000087346
|
Thra
|
thyroid hormone receptor alpha |
chr14_+_84447885 | 8.52 |
ENSRNOT00000009150
|
Gatsl3
|
GATS protein-like 3 |
chr3_+_72329967 | 8.40 |
ENSRNOT00000090256
|
Slc43a3
|
solute carrier family 43, member 3 |
chr8_+_116771982 | 8.39 |
ENSRNOT00000083240
|
AC128059.3
|
|
chr8_-_39093277 | 8.37 |
ENSRNOT00000043344
|
LOC100911068
|
roundabout homolog 4-like |
chr8_+_39878955 | 8.32 |
ENSRNOT00000060300
|
LOC100911068
|
roundabout homolog 4-like |
chr15_-_8931983 | 8.30 |
ENSRNOT00000085322
|
Thrb
|
thyroid hormone receptor beta |
chrX_-_106715391 | 8.30 |
ENSRNOT00000017138
|
Tceal8
|
transcription elongation factor A like 8 |
chr2_-_186515135 | 7.88 |
ENSRNOT00000077375
|
Kirrel
|
kin of IRRE like (Drosophila) |
chr7_+_117643206 | 7.70 |
ENSRNOT00000077588
|
Adck5
|
aarF domain containing kinase 5 |
chr16_+_80729400 | 7.65 |
ENSRNOT00000036383
|
Tdrp
|
testis development related protein |
chr14_+_37130743 | 7.57 |
ENSRNOT00000031756
|
Lrrc66
|
leucine rich repeat containing 66 |
chr10_+_84119884 | 7.54 |
ENSRNOT00000009951
|
Hoxb9
|
homeo box B9 |
chr2_-_188718704 | 7.52 |
ENSRNOT00000028010
|
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr9_-_116222374 | 7.46 |
ENSRNOT00000090111
ENSRNOT00000067900 |
Arhgap28
|
Rho GTPase activating protein 28 |
chr9_-_19476646 | 7.42 |
ENSRNOT00000013703
|
Enpp5
|
ectonucleotide pyrophosphatase/phosphodiesterase 5 |
chr4_+_113968995 | 7.35 |
ENSRNOT00000079511
|
Rtkn
|
rhotekin |
chr1_-_282251257 | 7.35 |
ENSRNOT00000015186
|
Prdx3
|
peroxiredoxin 3 |
chr10_+_90550147 | 7.13 |
ENSRNOT00000032944
|
Fzd2
|
frizzled class receptor 2 |
chr8_+_130581062 | 7.07 |
ENSRNOT00000014323
|
Fam198a
|
family with sequence similarity 198, member A |
chr20_-_3822754 | 7.05 |
ENSRNOT00000000541
ENSRNOT00000077357 |
Slc39a7
|
solute carrier family 39 member 7 |
chr1_+_266380973 | 7.01 |
ENSRNOT00000080509
|
Wbp1l
|
WW domain binding protein 1-like |
chr3_+_95232166 | 6.92 |
ENSRNOT00000017952
|
LOC691083
|
hypothetical protein LOC691083 |
chr1_-_170628915 | 6.90 |
ENSRNOT00000042865
|
Dchs1
|
dachsous cadherin-related 1 |
chrX_+_6791136 | 6.87 |
ENSRNOT00000003984
|
LOC100909913
|
norrin-like |
chr8_-_48597867 | 6.81 |
ENSRNOT00000077958
|
Nlrx1
|
NLR family member X1 |
chr17_-_32661865 | 6.55 |
ENSRNOT00000022194
|
Serpinb9
|
serpin family B member 9 |
chr7_+_1206648 | 6.53 |
ENSRNOT00000073689
|
Pros1
|
protein S (alpha) |
chr8_+_79323408 | 6.40 |
ENSRNOT00000088391
ENSRNOT00000090258 |
Nedd4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
chr18_-_70924708 | 6.11 |
ENSRNOT00000025257
|
Lipg
|
lipase G, endothelial type |
chr6_+_26387877 | 5.94 |
ENSRNOT00000076105
|
Fndc4
|
|
chr7_+_116357175 | 5.90 |
ENSRNOT00000076790
|
Ly6e
|
lymphocyte antigen 6 complex, locus E |
chr8_+_62925357 | 5.87 |
ENSRNOT00000011074
ENSRNOT00000090588 |
Stra6
|
stimulated by retinoic acid 6 |
chr6_-_114488880 | 5.86 |
ENSRNOT00000087560
|
AC118957.1
|
|
chr4_+_41364441 | 5.84 |
ENSRNOT00000087146
|
Foxp2
|
forkhead box P2 |
chr2_-_185303610 | 5.84 |
ENSRNOT00000093479
ENSRNOT00000046286 |
NEWGENE_1592020
|
protease, serine 48 |
chr12_-_1816414 | 5.82 |
ENSRNOT00000041155
ENSRNOT00000067448 |
Insr
|
insulin receptor |
chr10_+_56764927 | 5.79 |
ENSRNOT00000025308
|
Clec10a
|
C-type lectin domain family 10, member A |
chr14_-_45002719 | 5.77 |
ENSRNOT00000002883
|
Fam114a1
|
family with sequence similarity 114, member A1 |
chr10_-_95431312 | 5.75 |
ENSRNOT00000085552
|
AABR07030603.2
|
|
chr8_+_99880073 | 5.70 |
ENSRNOT00000010765
|
Plscr4
|
phospholipid scramblase 4 |
chr13_+_73929136 | 5.67 |
ENSRNOT00000005425
|
Nphs2
|
nephrosis 2, idiopathic, steroid-resistant |
chr1_-_247169693 | 5.66 |
ENSRNOT00000079875
|
Ak3
|
adenylate kinase 3 |
chr13_-_90832138 | 5.59 |
ENSRNOT00000010930
|
Igsf9
|
immunoglobulin superfamily, member 9 |
chr3_+_150910398 | 5.57 |
ENSRNOT00000055310
|
Tp53inp2
|
tumor protein p53 inducible nuclear protein 2 |
chr3_-_82756953 | 5.52 |
ENSRNOT00000044121
|
Accs
|
1-aminocyclopropane-1-carboxylate synthase homolog |
chr10_-_110863021 | 5.50 |
ENSRNOT00000071141
|
B3gntl1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 |
chr10_-_74298599 | 5.46 |
ENSRNOT00000007379
|
Ypel2
|
yippee-like 2 |
chr8_-_76579387 | 5.41 |
ENSRNOT00000090747
|
Fam81a
|
family with sequence similarity 81, member A |
chr7_-_12275609 | 5.34 |
ENSRNOT00000086061
|
Apc2
|
APC2, WNT signaling pathway regulator |
chr6_-_122721496 | 5.34 |
ENSRNOT00000079697
|
Ptpn21
|
protein tyrosine phosphatase, non-receptor type 21 |
chr14_-_45859908 | 5.34 |
ENSRNOT00000086994
|
Pgm2
|
phosphoglucomutase 2 |
chr4_+_120843453 | 5.23 |
ENSRNOT00000022534
|
Tpra1
|
transmembrane protein adipocyte associated 1 |
chr7_+_70807867 | 5.21 |
ENSRNOT00000010639
|
Stac3
|
SH3 and cysteine rich domain 3 |
chr20_+_5067330 | 5.07 |
ENSRNOT00000037482
|
Ly6g6e
|
lymphocyte antigen 6 complex, locus G6E |
chr4_+_162937774 | 5.06 |
ENSRNOT00000083188
|
Clec2g
|
C-type lectin domain family 2, member G |
chrX_-_157312028 | 5.05 |
ENSRNOT00000077979
|
Atp2b3
|
ATPase plasma membrane Ca2+ transporting 3 |
chr4_+_88834066 | 4.97 |
ENSRNOT00000009546
|
Abcg2
|
ATP-binding cassette, subfamily G (WHITE), member 2 |
chr6_+_107245820 | 4.89 |
ENSRNOT00000012757
|
Papln
|
papilin, proteoglycan-like sulfated glycoprotein |
chr1_+_114258719 | 4.86 |
ENSRNOT00000088459
ENSRNOT00000016376 |
Cyfip1
|
cytoplasmic FMR1 interacting protein 1 |
chr10_-_90030423 | 4.84 |
ENSRNOT00000092150
|
Mpp2
|
membrane palmitoylated protein 2 |
chr8_-_76579099 | 4.79 |
ENSRNOT00000088628
|
Fam81a
|
family with sequence similarity 81, member A |
chr7_+_117763783 | 4.76 |
ENSRNOT00000021208
|
Mfsd3
|
major facilitator superfamily domain containing 3 |
chr7_+_144577465 | 4.75 |
ENSRNOT00000021647
|
Hoxc10
|
homeo box C10 |
chr8_+_95968652 | 4.69 |
ENSRNOT00000015057
|
Nt5e
|
5' nucleotidase, ecto |
chr17_+_31493107 | 4.66 |
ENSRNOT00000023611
ENSRNOT00000086264 |
Tubb2a
|
tubulin, beta 2A class IIa |
chr7_-_143538579 | 4.63 |
ENSRNOT00000081518
|
Krt79
|
keratin 79 |
chr6_+_127333590 | 4.56 |
ENSRNOT00000063970
|
Ifi27
|
interferon, alpha-inducible protein 27 |
chr12_+_25173005 | 4.54 |
ENSRNOT00000033200
ENSRNOT00000091328 |
Clip2
|
CAP-GLY domain containing linker protein 2 |
chr2_-_33025271 | 4.51 |
ENSRNOT00000074941
|
NEWGENE_1310139
|
microtubule associated serine/threonine kinase family member 4 |
chr5_+_126812187 | 4.48 |
ENSRNOT00000057372
|
Ldlrad1
|
low density lipoprotein receptor class A domain containing 1 |
chr3_+_35679750 | 4.39 |
ENSRNOT00000059588
|
Lypd6
|
LY6/PLAUR domain containing 6 |
chr14_+_36689096 | 4.37 |
ENSRNOT00000083100
|
Usp46
|
ubiquitin specific peptidase 46 |
chr1_-_163328591 | 4.37 |
ENSRNOT00000034843
|
Tsku
|
tsukushi, small leucine rich proteoglycan |
chr7_-_116504853 | 4.37 |
ENSRNOT00000056557
|
RGD1565410
|
similar to Ly6-C antigen gene |
chr13_+_89586283 | 4.36 |
ENSRNOT00000079355
ENSRNOT00000049873 |
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr2_+_226563050 | 4.30 |
ENSRNOT00000065111
|
Bcar3
|
breast cancer anti-estrogen resistance 3 |
chr7_+_77966722 | 4.29 |
ENSRNOT00000006142
|
Cthrc1
|
collagen triple helix repeat containing 1 |
chr11_+_61083757 | 4.25 |
ENSRNOT00000002790
|
Boc
|
BOC cell adhesion associated, oncogene regulated |
chr1_+_198655742 | 4.19 |
ENSRNOT00000023944
|
Mylpf
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr13_+_89597138 | 4.14 |
ENSRNOT00000004662
|
Apoa2
|
apolipoprotein A2 |
chr1_-_19376301 | 4.14 |
ENSRNOT00000015547
|
Arhgap18
|
Rho GTPase activating protein 18 |
chr1_-_277181345 | 4.14 |
ENSRNOT00000038017
ENSRNOT00000038038 |
Nrap
|
nebulin-related anchoring protein |
chr2_-_147779013 | 4.12 |
ENSRNOT00000022778
|
Commd2
|
COMM domain containing 2 |
chr1_-_212622537 | 4.03 |
ENSRNOT00000025609
|
Sprn
|
shadow of prion protein homolog (zebrafish) |
chr15_+_83703791 | 3.98 |
ENSRNOT00000090637
|
Klf5
|
Kruppel-like factor 5 |
chrX_+_128416722 | 3.98 |
ENSRNOT00000009336
ENSRNOT00000085110 |
Xiap
|
X-linked inhibitor of apoptosis |
chr10_-_76813386 | 3.96 |
ENSRNOT00000032388
|
Nog
|
noggin |
chr20_+_5050327 | 3.94 |
ENSRNOT00000083353
|
Ddah2
|
dimethylarginine dimethylaminohydrolase 2 |
chr16_+_80729959 | 3.93 |
ENSRNOT00000082049
|
Tdrp
|
testis development related protein |
chr3_-_162579201 | 3.93 |
ENSRNOT00000068328
|
Zmynd8
|
zinc finger, MYND-type containing 8 |
chr16_-_81583916 | 3.89 |
ENSRNOT00000026281
|
LOC103693999
|
transmembrane and coiled-coil domain-containing protein 3 |
chr7_-_70476340 | 3.83 |
ENSRNOT00000006800
|
Arhgef25
|
Rho guanine nucleotide exchange factor 25 |
chr6_-_122572925 | 3.77 |
ENSRNOT00000090869
|
AC123293.2
|
|
chr3_+_113376983 | 3.76 |
ENSRNOT00000020478
|
Pdia3
|
protein disulfide isomerase family A, member 3 |
chr2_+_189922996 | 3.71 |
ENSRNOT00000016499
|
S100a16
|
S100 calcium binding protein A16 |
chr8_-_105462141 | 3.70 |
ENSRNOT00000066731
ENSRNOT00000078760 |
Clstn2
|
calsyntenin 2 |
chr7_-_12399910 | 3.68 |
ENSRNOT00000021677
|
RGD1562114
|
RGD1562114 |
chr19_+_43251539 | 3.64 |
ENSRNOT00000024793
|
Ddx19a
|
DEAD-box helicase 19A |
chr6_-_126320726 | 3.62 |
ENSRNOT00000010101
|
Lgmn
|
legumain |
chr13_-_35511020 | 3.61 |
ENSRNOT00000003413
|
Ralb
|
RAS like proto-oncogene B |
chr4_+_68634929 | 3.50 |
ENSRNOT00000081178
|
Ssbp1
|
single stranded DNA binding protein 1 |
chr10_+_83476107 | 3.49 |
ENSRNOT00000075733
|
Phb
|
prohibitin |
chr5_-_153252021 | 3.48 |
ENSRNOT00000023221
|
Tmem50a
|
transmembrane protein 50A |
chr10_+_53466870 | 3.40 |
ENSRNOT00000057503
|
Pirt
|
phosphoinositide-interacting regulator of transient receptor potential channels |
chr20_+_10265806 | 3.30 |
ENSRNOT00000001564
ENSRNOT00000086272 |
Ndufv3
|
NADH:ubiquinone oxidoreductase subunit V3 |
chr8_+_69484174 | 3.28 |
ENSRNOT00000077290
ENSRNOT00000056518 |
RGD1562747
|
similar to RIKEN cDNA 1110012L19 |
chr12_+_13323547 | 3.28 |
ENSRNOT00000074138
|
Zfp853
|
zinc finger protein 853 |
chr4_-_7311807 | 3.28 |
ENSRNOT00000012222
ENSRNOT00000089817 |
Abcb8
|
ATP binding cassette subfamily B member 8 |
chr5_+_155660553 | 3.25 |
ENSRNOT00000081893
|
Wnt4
|
wingless-type MMTV integration site family, member 4 |
chr7_-_70661891 | 3.25 |
ENSRNOT00000010240
|
Inhbc
|
inhibin beta C subunit |
chr13_-_50509916 | 3.23 |
ENSRNOT00000076747
|
Ren
|
renin |
chr18_-_28444880 | 3.18 |
ENSRNOT00000060696
|
Prob1
|
proline rich basic protein 1 |
chr7_+_120153184 | 3.17 |
ENSRNOT00000013538
|
Lgals1
|
galectin 1 |
chr8_+_5993941 | 3.13 |
ENSRNOT00000014065
|
Tmem123
|
transmembrane protein 123 |
chr7_-_138100841 | 3.10 |
ENSRNOT00000039002
|
Slc38a2
|
solute carrier family 38, member 2 |
chr1_+_216237697 | 3.04 |
ENSRNOT00000027760
|
Cd81
|
Cd81 molecule |
chr17_-_14627937 | 3.02 |
ENSRNOT00000020532
|
NEWGENE_1308171
|
osteoglycin |
chr20_-_32052855 | 2.97 |
ENSRNOT00000074989
|
LOC100364027
|
hexokinase 1-like |
chr16_-_20460959 | 2.97 |
ENSRNOT00000026457
|
Pde4c
|
phosphodiesterase 4C |
chr2_+_142262236 | 2.95 |
ENSRNOT00000019057
|
Lhfp
|
lipoma HMGIC fusion partner |
chr8_+_45797315 | 2.95 |
ENSRNOT00000059997
|
AABR07070046.1
|
|
chr14_-_7384876 | 2.95 |
ENSRNOT00000086694
|
Aff1
|
AF4/FMR2 family, member 1 |
chr2_-_23941084 | 2.91 |
ENSRNOT00000084729
|
Scamp1
|
secretory carrier membrane protein 1 |
chr7_+_116356324 | 2.89 |
ENSRNOT00000076407
ENSRNOT00000077022 ENSRNOT00000075873 |
Ly6e
|
lymphocyte antigen 6 complex, locus E |
chr8_+_55202725 | 2.88 |
ENSRNOT00000029166
|
Alg9
|
ALG9, alpha-1,2-mannosyltransferase |
chrX_+_71528988 | 2.83 |
ENSRNOT00000075963
|
Ogt
|
O-linked N-acetylglucosamine (GlcNAc) transferase |
chr4_-_148446303 | 2.81 |
ENSRNOT00000017633
|
Alox5
|
arachidonate 5-lipoxygenase |
chr17_+_6683152 | 2.81 |
ENSRNOT00000061249
|
RGD1311345
|
similar to CG9752-PA |
chr6_-_77243677 | 2.71 |
ENSRNOT00000011419
|
Mbip
|
MAP3K12 binding inhibitory protein 1 |
chr10_+_106828981 | 2.70 |
ENSRNOT00000073809
|
Afmid
|
arylformamidase |
chr11_+_46179940 | 2.68 |
ENSRNOT00000088152
|
Tfg
|
Trk-fused gene |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 29.9 | GO:0072714 | response to selenite ion(GO:0072714) negative regulation of connective tissue replacement(GO:1905204) |
9.3 | 27.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
7.8 | 31.1 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
7.7 | 30.6 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
7.1 | 21.2 | GO:0046864 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
6.7 | 20.1 | GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
5.2 | 15.6 | GO:0060849 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
5.1 | 15.4 | GO:1990401 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling(GO:0060683) embryonic lung development(GO:1990401) |
4.5 | 13.6 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
4.2 | 12.5 | GO:0017143 | insecticide metabolic process(GO:0017143) |
3.7 | 62.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
3.3 | 10.0 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
3.3 | 9.9 | GO:1990790 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
3.0 | 9.1 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
3.0 | 9.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.9 | 8.7 | GO:0031583 | phospholipase D-activating G-protein coupled receptor signaling pathway(GO:0031583) |
2.9 | 8.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
2.8 | 37.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
2.7 | 10.6 | GO:0031179 | peptide modification(GO:0031179) |
2.6 | 13.2 | GO:0001757 | somite specification(GO:0001757) |
2.6 | 18.2 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
2.5 | 17.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.4 | 7.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
2.3 | 6.9 | GO:0072137 | mitral valve formation(GO:0003192) condensed mesenchymal cell proliferation(GO:0072137) |
2.2 | 9.0 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
2.2 | 8.9 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
2.2 | 15.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
2.1 | 8.3 | GO:0008050 | female courtship behavior(GO:0008050) |
2.1 | 4.1 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
2.0 | 6.1 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
1.7 | 5.0 | GO:1904612 | glucuronoside metabolic process(GO:0019389) response to 2,3,7,8-tetrachlorodibenzodioxine(GO:1904612) |
1.6 | 9.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
1.6 | 3.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.6 | 4.9 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
1.6 | 4.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
1.5 | 7.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.4 | 5.7 | GO:0072248 | metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.4 | 5.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.3 | 4.0 | GO:0060825 | regulation of cytokine activity(GO:0060300) fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.3 | 6.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.3 | 15.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.3 | 3.8 | GO:2000853 | negative regulation of corticosterone secretion(GO:2000853) |
1.2 | 3.6 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
1.2 | 9.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.1 | 12.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.1 | 8.7 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
1.1 | 4.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
1.0 | 3.0 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
1.0 | 3.9 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
1.0 | 6.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.0 | 5.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.9 | 3.8 | GO:1903334 | response to benzene(GO:1901423) positive regulation of protein folding(GO:1903334) |
0.9 | 9.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.9 | 4.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.9 | 2.6 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.8 | 19.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.8 | 7.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.8 | 5.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.8 | 2.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of renin secretion into blood stream(GO:1900135) |
0.8 | 7.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 5.8 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.8 | 3.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.8 | 11.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.8 | 20.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.7 | 5.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.7 | 2.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 2.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.7 | 33.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.7 | 4.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.6 | 3.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 3.8 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.6 | 1.9 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.6 | 3.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 1.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.6 | 13.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.5 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.1 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.5 | 7.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.5 | 8.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.5 | 2.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 5.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 1.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.5 | 1.8 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.4 | 14.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.4 | 5.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 1.7 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.4 | 4.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 4.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 0.7 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
0.3 | 1.0 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.3 | 12.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 2.4 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 17.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 12.3 | GO:0097178 | ruffle assembly(GO:0097178) |
0.3 | 9.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 5.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 6.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 2.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 9.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 4.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 5.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.3 | 16.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 10.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 3.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.0 | GO:0038109 | Kit signaling pathway(GO:0038109) diapedesis(GO:0050904) |
0.3 | 17.9 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.2 | 2.7 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 3.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 2.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 2.6 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.2 | 7.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 4.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 1.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 4.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 4.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 1.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 9.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 13.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 3.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 4.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 4.6 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 3.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 2.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 1.8 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.1 | 1.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 1.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 5.3 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.4 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 3.7 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.1 | 1.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 3.0 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 1.3 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 1.5 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 2.9 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 1.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 3.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 9.3 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.1 | 2.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 5.6 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 2.5 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 7.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.7 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 8.4 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 1.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 3.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 3.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 2.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 3.4 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 2.9 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 1.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 3.0 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 1.2 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 30.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
4.4 | 62.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
3.1 | 31.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.4 | 28.5 | GO:0005861 | troponin complex(GO:0005861) |
2.3 | 9.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.9 | 5.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.9 | 13.2 | GO:1990357 | terminal web(GO:1990357) |
1.5 | 8.7 | GO:0033093 | Weibel-Palade body(GO:0033093) rough endoplasmic reticulum lumen(GO:0048237) |
0.9 | 10.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.8 | 17.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.8 | 4.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 3.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 16.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 5.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 4.5 | GO:0042599 | lamellar body(GO:0042599) |
0.5 | 30.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.5 | 4.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 7.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 3.8 | GO:0042825 | TAP complex(GO:0042825) |
0.5 | 4.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 4.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 2.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 8.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 5.3 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 16.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 4.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.2 | 21.8 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 2.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.8 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 5.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.2 | 11.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 15.5 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 3.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 5.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 2.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 9.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 2.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 13.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 6.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 24.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 11.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 10.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 9.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.3 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 3.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 4.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 20.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 3.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 4.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 5.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 2.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 3.7 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 37.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 6.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 47.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 4.3 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 6.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 2.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 2.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 3.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 9.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 2.4 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 25.6 | GO:1903561 | extracellular vesicle(GO:1903561) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 29.9 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
5.8 | 51.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
5.1 | 15.2 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
4.2 | 20.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
4.1 | 28.5 | GO:0031014 | troponin T binding(GO:0031014) |
3.7 | 11.0 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
3.5 | 10.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
3.2 | 16.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.9 | 11.6 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
2.9 | 8.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.9 | 22.9 | GO:0008430 | selenium binding(GO:0008430) |
2.5 | 65.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
2.3 | 9.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.3 | 9.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
2.3 | 9.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
2.3 | 18.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
2.2 | 17.6 | GO:0016936 | galactoside binding(GO:0016936) |
2.2 | 17.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.9 | 21.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.9 | 21.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.8 | 7.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.8 | 8.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.7 | 8.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.6 | 3.2 | GO:0048030 | disaccharide binding(GO:0048030) |
1.6 | 14.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.4 | 12.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.4 | 4.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.3 | 3.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.3 | 6.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.2 | 15.3 | GO:0019841 | retinol binding(GO:0019841) |
1.2 | 3.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.1 | 15.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.1 | 5.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.1 | 21.0 | GO:0010181 | FMN binding(GO:0010181) |
1.0 | 6.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.0 | 6.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.0 | 13.6 | GO:0005542 | folic acid binding(GO:0005542) |
1.0 | 18.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.9 | 2.8 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.9 | 3.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 2.8 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.9 | 31.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.9 | 25.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.8 | 2.5 | GO:0031694 | beta-adrenergic receptor activity(GO:0004939) alpha-2A adrenergic receptor binding(GO:0031694) |
0.8 | 18.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 2.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 13.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.6 | 7.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.6 | 5.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.5 | 2.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.5 | 5.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 7.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 5.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 1.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.4 | 15.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.4 | 4.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 9.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.4 | 1.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 3.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 10.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 3.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 1.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 5.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 4.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 17.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 9.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 5.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 6.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 5.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 4.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 2.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 4.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 9.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 11.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 2.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 4.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 4.8 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.2 | 13.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 5.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 11.3 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.2 | 5.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 3.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 4.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 2.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 2.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 4.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 7.9 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 22.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 7.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 2.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 3.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 17.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 3.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 6.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 2.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) MutSalpha complex binding(GO:0032407) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 5.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 4.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 11.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 3.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 1.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 4.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.0 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 1.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 2.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 1.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 1.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 3.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 1.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 1.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 1.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 3.1 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 1.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 46.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.9 | 50.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 9.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 10.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 26.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 10.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 24.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 18.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 17.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 17.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 13.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 17.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 14.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 5.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 13.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 18.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 43.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 9.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 4.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 6.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 3.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 5.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 17.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 2.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 6.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 4.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 9.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 2.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.7 | 55.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.1 | 29.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.4 | 31.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.3 | 21.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.2 | 17.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.2 | 17.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.2 | 15.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.1 | 13.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.9 | 9.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 28.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 9.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 10.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 5.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 4.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 8.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.5 | 17.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 3.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 3.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 5.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 3.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 10.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 5.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 4.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 10.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 5.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 5.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 3.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 5.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 2.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 2.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 1.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 16.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 24.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 2.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 8.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 4.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 10.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 4.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 13.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 10.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 6.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 5.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 4.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 16.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 4.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 3.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 6.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 8.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 5.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |